Clinical Trials Logo

Nephrogenic Fibrosing Dermopathy clinical trials

View clinical trials related to Nephrogenic Fibrosing Dermopathy.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT00811863 Withdrawn - Renal Insufficiency Clinical Trials

Evaluation of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Following OptiMARK Injection

SHERLOC
Start date: February 2009
Phase: N/A
Study type: Observational

The objective of this study is to prospectively monitor the incidence of adverse drug reactions, specifically NSF during routine use of gadoversetamide in a large number of patients with moderate renal insufficiency (eGFR 30-59) and severe renal insufficiency or end-stage renal disease requiring dialysis (eGFR <30).